Literature DB >> 20386499

Apheresis of activated leukocytes with an immobilized polymyxin B filter in patients with septic shock.

Tuneyasu Kumagai1, Naoshi Takeyama, Teru Yabuki, Makoto Harada, Yasuo Miki, Hideki Kanou, Sousuke Inoue, Takashi Nakagawa, Hiroshi Noguchi.   

Abstract

In this study, we examined the effects of direct hemoperfusion through filters with immobilized polymyxin B (PMX-DHP) on leukocyte function and plasma levels of cytokines in patients with septic shock. We found that PMX-DHP caused increased expression of C-X-C chemokine receptor 1 (CXCR1) and CXCR2, along with decreased expression of CD64 and CD11b, by circulating neutrophils in patients with septic shock. Plasma levels of cytokines, including interleukin 6 (IL-6), IL-8, IL-10, and high-mobility group box 1, were elevated in patients with septic shock compared with healthy controls, but cytokine levels were not altered by PMX-DHP. These results suggest that PMX-DHP influences neutrophils via a mechanism that does not involve cytokine. Ex vivo perfusion of heparinized blood from patients with sepsis and septic shock through PMX filters in a laboratory circuit caused a significant decrease in neutrophil and monocyte counts. After 120 min of perfusion, neutrophils, monocytes, and lymphocytes were decreased by 78%, 70%, and 10%, respectively, compared with baseline values. Flow cytometric analysis indicated that activated neutrophils with high levels of CD11b/CD64 expression and low levels of CXCR1/CXCR2 expression showed preferential adhesion to PMX filters. Neutrophils isolated from the blood after ex vivo PMX perfusion caused less damage to an endothelial cell monolayer than cells from sham-treated blood, whereas neutrophil phagocytosis of opsonized Escherichia coli was unaffected. These results indicate that PMX-DHP selectively removes activated neutrophils and reduces the ability of circulating cells to cause endothelial damage. Selective removal of activated neutrophils using PMX-DHP may improve the systemic inflammatory response in patients with septic shock.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386499     DOI: 10.1097/SHK.0b013e3181e14ca0

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  15 in total

Review 1.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

Review 2.  Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe.

Authors:  Koichi Sato; Hiroshi Maekawa; Mutsumi Sakurada; Hajime Orita; Yoshihiro Komatsu
Journal:  Surg Today       Date:  2011-06       Impact factor: 2.549

Review 3.  IMMUNE CELL PHENOTYPE AND FUNCTION IN SEPSIS.

Authors:  Thomas Rimmelé; Didier Payen; Vincenzo Cantaluppi; John Marshall; Hernando Gomez; Alonso Gomez; Patrick Murray; John A Kellum
Journal:  Shock       Date:  2016-03       Impact factor: 3.454

4.  Broad spectrum immunomodulation using biomimetic blood cell margination for sepsis therapy.

Authors:  Han Wei Hou; Lidan Wu; Diana P Amador-Munoz; Miguel Pinilla Vera; Anna Coronata; Joshua A Englert; Bruce D Levy; Rebecca M Baron; Jongyoon Han
Journal:  Lab Chip       Date:  2016-01-15       Impact factor: 6.799

5.  Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study.

Authors:  Reshma Basu; Sunjay Pathak; Jyoti Goyal; Rajeev Chaudhry; Rati B Goel; Anil Barwal
Journal:  Indian J Crit Care Med       Date:  2014-12

6.  Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo study.

Authors:  Thomas Rimmelé; Ata Murat Kaynar; Joseph N McLaughlin; Jeffery V Bishop; Morgan V Fedorchak; Anan Chuasuwan; Zhiyong Peng; Kai Singbartl; Daniel R Frederick; Lin Zhu; Melinda Carter; William J Federspiel; Adriana Zeevi; John A Kellum
Journal:  Crit Care       Date:  2013-03-26       Impact factor: 9.097

7.  Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.

Authors:  Toshiaki Iba; Isao Nagaoka; Atsushi Yamada; Masataka Nagayama; Takahiro Miki
Journal:  Int J Med Sci       Date:  2014-01-17       Impact factor: 3.738

Review 8.  Immunomodulation in sepsis: the role of endotoxin removal by polymyxin B-immobilized cartridge.

Authors:  Elisabeth Esteban; Ricard Ferrer; Laia Alsina; Antonio Artigas
Journal:  Mediators Inflamm       Date:  2013-10-22       Impact factor: 4.711

9.  Modulation of chemokine gradients by apheresis redirects leukocyte trafficking to different compartments during sepsis, studies in a rat model.

Authors:  Zhi-Yong Peng; Jeffery V Bishop; Xiao-Yan Wen; Michele M Elder; Feihu Zhou; Anan Chuasuwan; Melinda J Carter; Jason E Devlin; A Murat Kaynar; Kai Singbartl; Francis Pike; Robert S Parker; Gilles Clermont; William J Federspiel; John A Kellum
Journal:  Crit Care       Date:  2014-07-03       Impact factor: 9.097

10.  CMTM8 inhibits the carcinogenesis and progression of bladder cancer.

Authors:  Denghui Gao; Hao Hu; Ying Wang; Weidong Yu; Jianhua Zhou; Xiaofeng Wang; Weiping Wang; Chunyan Zhou; Kexin Xu
Journal:  Oncol Rep       Date:  2015-12       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.